Baidu
map

Sci Transl Med:修复肌营养不良症中细胞损伤的蛋白

2012-07-03 EurekAlert! EurekAlert!

据一项刊登在国际著名杂志Science Translational Medicine上的研究报道,提高一种自然产生的能修复损伤细胞的蛋白质的水平可能令罹患杜氏肌营养不良症(DMD)的患者受益。DMD是一种主要影响男性的进行性肌肉消耗性疾病。 DMD是由肌纤维中的肌营养不良蛋白基因的突变引起的,DMD是肌营养不良症的最常见的流行形式。患者通常无法活过青少年时期,且此病无法治愈。 Noah Wei

据一项刊登在国际著名杂志Science Translational Medicine上的研究报道,提高一种自然产生的能修复损伤细胞的蛋白质的水平可能令罹患杜氏肌营养不良症(DMD)的患者受益。DMD是一种主要影响男性的进行性肌肉消耗性疾病。

DMD是由肌纤维中的肌营养不良蛋白基因的突变引起的,DMD是肌营养不良症的最常见的流行形式。患者通常无法活过青少年时期,且此病无法治愈。

Noah Weisleder及其同事展示,给患有DMD样疾病的小鼠注射大量的重组MG53蛋白可减轻肌肉的损伤。就像是一名机修工给漏气的轮胎打补丁一样,该蛋白会与受损肌肉细胞的细胞膜结合并将其封闭。

一则相关的《焦点》文章写道,MG53成为不断增加的新近研发出来的疗法名录中的一员,这些疗法在小鼠DMD模型中显示出了治疗该疾病的希望。

doi:10.1126/scitranslmed.3003921
PMC:
PMID:

Recombinant MG53 Protein Modulates Therapeutic Cell Membrane Repair in Treatment of Muscular Dystrophy

Noah Weisleder1,2,*, Norio Takizawa2, Peihui Lin1, Xianhua Wang3, Chunmei Cao3, Yan Zhang3, Tao Tan2, Christopher Ferrante2, Hua Zhu1, Pin-Jung Chen2, Rosalie Yan2, Matthew Sterling1, Xiaoli Zhao1, Moonsun Hwang1, Miyuki Takeshima4, Chuanxi Cai1, Heping Cheng3, Hiroshi Takeshima4, Rui-Ping Xiao3 and Jianjie Ma1,2,*

Mitsugumin 53 (MG53), a muscle-specific TRIM family protein, is an essential component of the cell membrane repair machinery. Here, we examined the translational value of targeting MG53 function in tissue repair and regenerative medicine. Although native MG53 protein is principally restricted to skeletal and cardiac muscle tissues, beneficial effects that protect against cellular injuries are present in nonmuscle cells with overexpression of MG53. In addition to the intracellular action of MG53, injury to the cell membrane exposes a signal that can be detected by MG53, allowing recombinant MG53 protein to repair membrane damage when provided in the extracellular space. Recombinant human MG53 (rhMG53) protein purified from Escherichia coli fermentation provided dose-dependent protection against chemical, mechanical, or ultraviolet-induced damage to both muscle and nonmuscle cells. Injection of rhMG53 through multiple routes decreased muscle pathology in the mdx dystrophic mouse model. Our data support the concept of targeted cell membrane repair in regenerative medicine, and present MG53 protein as an attractive biological reagent for restoration of membrane repair defects in human diseases.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1656532, encodeId=07ff1656532b0, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat May 04 20:08:00 CST 2013, time=2013-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737021, encodeId=819a1e370219e, content=<a href='/topic/show?id=6ee1810e0ad' target=_blank style='color:#2F92EE;'>#肌营养不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81070, encryptionId=6ee1810e0ad, topicName=肌营养不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd6034244098, createdName=751943081_32627960, createdTime=Sun Dec 23 13:08:00 CST 2012, time=2012-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007037, encodeId=a1ef200e03775, content=<a href='/topic/show?id=21fe810e29d' target=_blank style='color:#2F92EE;'>#肌营养不良症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81072, encryptionId=21fe810e29d, topicName=肌营养不良症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Wed Apr 17 06:08:00 CST 2013, time=2013-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067096, encodeId=ddf3206e096ff, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Thu Nov 01 19:08:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396705, encodeId=8ac91396e050f, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605769, encodeId=85a51605e693e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=)]
    2013-05-04 bsmagic9140
  2. [GetPortalCommentsPageByObjectIdResponse(id=1656532, encodeId=07ff1656532b0, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat May 04 20:08:00 CST 2013, time=2013-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737021, encodeId=819a1e370219e, content=<a href='/topic/show?id=6ee1810e0ad' target=_blank style='color:#2F92EE;'>#肌营养不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81070, encryptionId=6ee1810e0ad, topicName=肌营养不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd6034244098, createdName=751943081_32627960, createdTime=Sun Dec 23 13:08:00 CST 2012, time=2012-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007037, encodeId=a1ef200e03775, content=<a href='/topic/show?id=21fe810e29d' target=_blank style='color:#2F92EE;'>#肌营养不良症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81072, encryptionId=21fe810e29d, topicName=肌营养不良症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Wed Apr 17 06:08:00 CST 2013, time=2013-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067096, encodeId=ddf3206e096ff, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Thu Nov 01 19:08:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396705, encodeId=8ac91396e050f, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605769, encodeId=85a51605e693e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1656532, encodeId=07ff1656532b0, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat May 04 20:08:00 CST 2013, time=2013-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737021, encodeId=819a1e370219e, content=<a href='/topic/show?id=6ee1810e0ad' target=_blank style='color:#2F92EE;'>#肌营养不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81070, encryptionId=6ee1810e0ad, topicName=肌营养不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd6034244098, createdName=751943081_32627960, createdTime=Sun Dec 23 13:08:00 CST 2012, time=2012-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007037, encodeId=a1ef200e03775, content=<a href='/topic/show?id=21fe810e29d' target=_blank style='color:#2F92EE;'>#肌营养不良症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81072, encryptionId=21fe810e29d, topicName=肌营养不良症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Wed Apr 17 06:08:00 CST 2013, time=2013-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067096, encodeId=ddf3206e096ff, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Thu Nov 01 19:08:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396705, encodeId=8ac91396e050f, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605769, encodeId=85a51605e693e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1656532, encodeId=07ff1656532b0, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat May 04 20:08:00 CST 2013, time=2013-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737021, encodeId=819a1e370219e, content=<a href='/topic/show?id=6ee1810e0ad' target=_blank style='color:#2F92EE;'>#肌营养不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81070, encryptionId=6ee1810e0ad, topicName=肌营养不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd6034244098, createdName=751943081_32627960, createdTime=Sun Dec 23 13:08:00 CST 2012, time=2012-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007037, encodeId=a1ef200e03775, content=<a href='/topic/show?id=21fe810e29d' target=_blank style='color:#2F92EE;'>#肌营养不良症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81072, encryptionId=21fe810e29d, topicName=肌营养不良症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Wed Apr 17 06:08:00 CST 2013, time=2013-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067096, encodeId=ddf3206e096ff, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Thu Nov 01 19:08:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396705, encodeId=8ac91396e050f, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605769, encodeId=85a51605e693e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1656532, encodeId=07ff1656532b0, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat May 04 20:08:00 CST 2013, time=2013-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737021, encodeId=819a1e370219e, content=<a href='/topic/show?id=6ee1810e0ad' target=_blank style='color:#2F92EE;'>#肌营养不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81070, encryptionId=6ee1810e0ad, topicName=肌营养不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd6034244098, createdName=751943081_32627960, createdTime=Sun Dec 23 13:08:00 CST 2012, time=2012-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007037, encodeId=a1ef200e03775, content=<a href='/topic/show?id=21fe810e29d' target=_blank style='color:#2F92EE;'>#肌营养不良症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81072, encryptionId=21fe810e29d, topicName=肌营养不良症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Wed Apr 17 06:08:00 CST 2013, time=2013-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067096, encodeId=ddf3206e096ff, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Thu Nov 01 19:08:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396705, encodeId=8ac91396e050f, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605769, encodeId=85a51605e693e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1656532, encodeId=07ff1656532b0, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat May 04 20:08:00 CST 2013, time=2013-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737021, encodeId=819a1e370219e, content=<a href='/topic/show?id=6ee1810e0ad' target=_blank style='color:#2F92EE;'>#肌营养不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81070, encryptionId=6ee1810e0ad, topicName=肌营养不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd6034244098, createdName=751943081_32627960, createdTime=Sun Dec 23 13:08:00 CST 2012, time=2012-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007037, encodeId=a1ef200e03775, content=<a href='/topic/show?id=21fe810e29d' target=_blank style='color:#2F92EE;'>#肌营养不良症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81072, encryptionId=21fe810e29d, topicName=肌营养不良症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Wed Apr 17 06:08:00 CST 2013, time=2013-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067096, encodeId=ddf3206e096ff, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Thu Nov 01 19:08:00 CST 2012, time=2012-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1396705, encodeId=8ac91396e050f, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605769, encodeId=85a51605e693e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Jul 05 07:08:00 CST 2012, time=2012-07-05, status=1, ipAttribution=)]

相关资讯

Sci Transl Med :杀死登革病毒的人源抗体

近日,新加坡和英国的科学家分离出了一种人类抗体,能够有效地消除蚊子传播的登革热病毒。登革热是登革热病毒引起、依蚊传播的一种急性传染病,病人和隐性感染者是主要传染源。临床特征为起病急骤,高热,全身肌肉、骨髓及关节痛,极度疲乏,部分患可有皮疹、出血倾向和淋巴结肿大。 登革热由登革病毒感染引起,登革病毒属B组虫媒病毒,黄病毒科黄病毒属(flavivirus)。病毒基因编码3个结构蛋白和7个非结构蛋

Cancer Sci:抑制清道夫受体治疗肿瘤转移

清道夫受体(scavenger receptor)是吞噬细胞表面的一组异质性分子,至少以6种不同的分子形式存在。此类受体多见于巨噬细胞表面,它们以化学修饰的蛋白质、多核苷酸、多糖和磷脂等为配体并可促进其胞吞作用,起着清除体内有毒物质和衰老、凋亡或坏死细胞的作用。 清道夫受体成员5(SCARA5)是一类清道夫受体新成员,在人类肝细胞癌(HCC)中是一种新的候选肿瘤抑制基因。 近日刊登在Cance

Cancer Sci:ZEB1促进小细胞肺癌骨转移

骨是小细胞肺癌(SCLC)转移的最常见的远端器官之一,小细胞肺癌转移至骨的癌症患者往往预后不良,但到底是什么特异性细胞基调控小细胞肺癌的骨转移,目前还不清楚。 ZEB1是E-box转录抑制因子,早期研究发现ZEB1对诱导上皮间质转化(EMT)和结肠癌、乳腺癌和肺癌等肿瘤的转移至关重要。然而,ZEB1和小细胞肺癌骨转移之间的关系目前还不清楚。 近日发表在Cancer Sci杂志上的一则研究证实,

Cancer Sci:胃癌患者生存独立预后因素Snail

近日,Cancer Sci杂志上刊登的一项研究中,肿瘤工作者探讨分析了Snail的临床意义,Snail是一种锌指转录因子,存在于胃癌的发展过程中。 为了阐明Snail表达与胃癌细胞肿瘤干细胞样表型和分化状态之间的关系,研究人员采用免疫印迹、RT-PCR技术、实时定量PCR和流式细胞仪技术。 免疫组织化学染色和评价10例正常胃标本以及103临床癌症患者Snail的表达特征,统计分析发现胃癌组织中

从ASL期刊被剔除SCI看中科院SCI分区之荒谬

近日,2011年SCI影响因子即将公布,很多人都是拭目以待,看看那些期刊的影响因子有没有上涨。如果自己发表的论文的期刊影响因子高了,那值得庆幸,下次吹牛的时候,“分”又要增加了。同时期刊影响因子见长,被中科院的SCI分区表提高了,有可以更新一下自己的简历,有多少1区期刊,有多少2区期刊。如果论文发表在3区期刊上面,肯定比4区期刊上要强。此时,不知道科学网上江湖人物是否又要风波再起,要持锋刀利剑相互

Baidu
map
Baidu
map
Baidu
map